000 | 01479 a2200457 4500 | ||
---|---|---|---|
005 | 20250512135800.0 | ||
264 | 0 | _c19701006 | |
008 | 197010s 0 0 eng d | ||
022 | _a0029-7844 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWhite, C A | |
245 | 0 | 0 |
_aRho (D) immune prophylaxis. A double-blind cooperative study. _h[electronic resource] |
260 |
_bObstetrics and gynecology _cSep 1970 |
||
300 |
_a341-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAntibodies, Anti-Idiotypic |
650 | 0 | 4 |
_aBlood Group Incompatibility _xprevention & control |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCoombs Test |
650 | 0 | 4 | _aDelivery, Obstetric |
650 | 0 | 4 | _aDesensitization, Immunologic |
650 | 0 | 4 | _aErythrocytes |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFetomaternal Transfusion _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity |
650 | 0 | 4 | _aImmunoglobulin G |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aInjections, Intramuscular |
650 | 0 | 4 | _aMaternal-Fetal Exchange |
650 | 0 | 4 | _aPlacenta |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications, Hematologic _xprevention & control |
650 | 0 | 4 | _aRh-Hr Blood-Group System |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUmbilical Cord |
700 | 1 | _aVisscher, R D | |
700 | 1 | _aVisscher, H C | |
700 | 1 | _aWade, M E | |
773 | 0 |
_tObstetrics and gynecology _gvol. 36 _gno. 3 _gp. 341-6 |
|
999 |
_c4991519 _d4991519 |